Vol 12, No 6 (December 31, 2023): Chinese Clinical Oncology

Original Article

Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis
Alejandro Olivares-Hernández, Jonnathan Roldán-Ruiz, José Pablo Miramontes-González, Irene Toribio-García, Juan Luis García-Hernández, Luis Posado-Domínguez, Lorena Bellido-Hernández, Juan Jesús Cruz-Hernández, Emilio Fonseca-Sánchez, Edel del Barco-Morillo
Chinese Clinical Oncology  
2023;
12
(6)
:62
.
Establishment and validation of a prognostic model for gastric cancer patients of Hebei Province in China
Yahui Hao, Daojuan Li, Di Liang, Yanyu Liu, Shuo Zhang, Yutong He
Chinese Clinical Oncology  
2023;
12
(6)
:63
.

Review Article

Tumor treating fields: narrative review of a promising treatment modality for cancer
Tugce Kutuk, Ece Atak, Alonso La Rosa, Rupesh Kotecha, Minesh P. Mehta, Michael D. Chuong
Chinese Clinical Oncology  
2023;
12
(6)
:64
.
Twenty-five years with companion diagnostics
Jan Trøst Jørgensen
Chinese Clinical Oncology  
2023;
12
(6)
:65
.
A systematic review of undifferentiated pleomorphic sarcoma of the chest wall
Cade Bennett, Sandeep Bharadwaj, Andrew Arndt, Akhil Chawla
Chinese Clinical Oncology  
2023;
12
(6)
:66
.
Advances in understanding and management of high-grade pancreatic neuroendocrine neoplasm: a comprehensive review
Dileep Kumar Reddy Regalla, Ojasvi Deep, Ravi Kumar Paluri
Chinese Clinical Oncology  
2023;
12
(6)
:67
.
Hyperthermic intraperitoneal chemotherapy for gastric cancer: a narrative review
Courtney Chen, Monica Justo, Alexandra Gangi
Chinese Clinical Oncology  
2023;
12
(6)
:68
.

Case Report

Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatment
Alex M. DesJarlais, Ryan Miller, Ayesha S. Ali, Muneeb Z. Niazi, Louis Cappelli, Jon Glass, Christopher J. Farrell, Wenyin Shi
Chinese Clinical Oncology  
2023;
12
(6)
:69
.
Left total pneumonectomy performed after alectinib treatment for anaplastic lymphoma kinase-positive lung adenocarcinoma: a case report
Zirong Wang, Yu Shi, Peng Zhang, Yuan Chen
Chinese Clinical Oncology  
2023;
12
(6)
:70
.